Whittier Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$21.9K Hold
94
– – ﹤0.01% 1011
2026
Q2
$29.4K Buy
94
+4
+4% +$1.21K ﹤0.01% 960
2026
Q1
$29.7K Buy
90
+21
+30% +$7.15K ﹤0.01% 926
2025
Q4
$28K Hold
69
– – ﹤0.01% 966
2025
Q3
$31.5K Hold
69
– – ﹤0.01% 938
2025
Q2
$22.5K Buy
69
+33
+92% +$9.13K ﹤0.01% 1084
2025
Q1
$9.7K Hold
36
– – ﹤0.01% 1217
2024
Q4
$8.47K Hold
36
– – ﹤0.01% 1277
2024
Q3
$9.9K Hold
36
– – ﹤0.01% 1264
2024
Q2
$8.75K Hold
36
– – ﹤0.01% 1265
2024
Q1
$5.38K Sell
36
-1
-3% -$167 ﹤0.01% 1347
2023
Q4
$7.08K Sell
37
-1
-3% -$170 ﹤0.01% 1274
2023
Q3
$6.73K Buy
38
+2
+6% +$382 ﹤0.01% 1325
2023
Q2
$6.84K Hold
36
– – ﹤0.01% 1322
2023
Q1
$7.21K Sell
36
-6
-14% -$1.26K ﹤0.01% 1350
2022
Q4
$10K Buy
42
+6
+17% +$1.28K ﹤0.01% 1289
2022
Q3
$7K Hold
36
– – ﹤0.01% 1387
2022
Q2
$5K Hold
36
– – ﹤0.01% 1427
2022
Q1
$6K Hold
36
– – ﹤0.01% 1414
2021
Q4
$6K Hold
36
– – ﹤0.01% 1379
2021
Q3
$7K Hold
36
– – ﹤0.01% 1287
2021
Q2
$6K Hold
36
– – ﹤0.01% 1332
2021
Q1
$5K Hold
36
– – ﹤0.01% 1344
2020
Q4
$5K Hold
36
– – ﹤0.01% 1232
2020
Q3
$5K Hold
36
– – ﹤0.01% 1216
2020
Q2
$5K Hold
36
– – ﹤0.01% 1157
2020
Q1
$4K Sell
36
-28
-44% -$3.23K ﹤0.01% 1234
2019
Q4
$7K Buy
64
+28
+78% +$2.79K ﹤0.01% 1181
2019
Q3
$3K Buy
+36
New +$2.85K ﹤0.01% 1314

Other funds holding ALNY

Whittier Trust's ALNY Position: Q3 2026 in Review

Whittier Trust held its Alnylam Pharmaceuticals (ALNY) position steady in Q3 2026 at 94 shares worth $21.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1011.

Whittier Trust first reported a position in ALNY in Q3 2019 and has held it in 29 quarters since. The position peaked at $31.5K in Q3 2025. 720 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

  • Whittier Trust held 94 shares of Alnylam Pharmaceuticals worth $21.9K as of Q3 2026.
  • Whittier Trust left its Alnylam Pharmaceuticals share count unchanged in Q3 2026.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Whittier Trust's portfolio in Q3 2026, its #1011 holding.
  • Whittier Trust first reported a position in Alnylam Pharmaceuticals in Q3 2019 and has held it in 29 quarters since.
  • Whittier Trust's Alnylam Pharmaceuticals position peaked at $31.5K in Q3 2025.
  • 720 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on Whittier Trust's 13F filing for Q3 2026, filed 12 Nov 2026.